Neuronetics, Inc.
STIM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $37 | $38 | $32 | $22 |
| % Growth | -2.1% | 19.2% | 42.2% | – |
| Cost of Goods Sold | $20 | $20 | $16 | $8 |
| Gross Profit | $17 | $18 | $16 | $15 |
| % Margin | 45.9% | 46.6% | 49.2% | 66.2% |
| R&D Expenses | $2 | $2 | $2 | $6 |
| G&A Expenses | $11 | $12 | $13 | $11 |
| SG&A Expenses | $23 | $24 | $25 | $21 |
| Sales & Mktg Exp. | $12 | $12 | $12 | $10 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $24 | $26 | $27 | $26 |
| Operating Income | -$7 | -$8 | -$11 | -$11 |
| % Margin | -19.6% | -21.1% | -34.4% | -51% |
| Other Income/Exp. Net | -$2 | -$2 | -$2 | -$1 |
| Pre-Tax Income | -$9 | -$10 | -$13 | -$13 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9 | -$10 | -$13 | -$13 |
| % Margin | -24.3% | -26.6% | -39.6% | -56.3% |
| EPS | -0.13 | -0.15 | -0.21 | -0.33 |
| % Growth | 13.3% | 28.6% | 36.4% | – |
| EPS Diluted | -0.13 | -0.15 | -0.21 | -0.33 |
| Weighted Avg Shares Out | 67 | 66 | 61 | 37 |
| Weighted Avg Shares Out Dil | 67 | 66 | 61 | 37 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $2 | $2 | $2 |
| Depreciation & Amortization | $1 | $1 | $1 | $0 |
| EBITDA | -$6 | -$7 | -$10 | -$11 |
| % Margin | -17.3% | -18.8% | -30.8% | -47.5% |